Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum -lactamase production in clinical Enterobacteriaceae isolates | Zendy

Silke Polsfuß | Zendy; Guido V. Bloemberg | Zendy; J. Giger | Zendy; Vera Meyer | Zendy; Michael Hombach | Zendy

Open Access

Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum -lactamase production in clinical Enterobacteriaceae isolates

Author(s) -

Silke Polsfuß,

Guido V. Bloemberg,

J. Giger,

Vera Meyer,

Michael Hombach

Publication year - 2011

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkr400

Subject(s) - cefotaxime , ceftazidime , cefpodoxime , cefepime , clavulanic acid , microbiology and biotechnology , medicine , biology , amoxicillin , antibiotics , antibiotic resistance , imipenem , bacteria , genetics , pseudomonas aeruginosa

To compare the performance of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI breakpoints following their revision in 2010, for the detection of extended-spectrum β-lactamase (ESBL) production in Enterobacteriaceae.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research